ArticleCancers2019

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.

Arsela Prelaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.